The Community Guide

- gsearch

Search Results

Narrow Results:

2020 1

HPV-IMPACT Working Group 1

Journal Article 1

1 Results

Refine Results

Refine Results:

Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18

CITE Title : Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18 Personal Author(s) : Johnson Jones, Michelle L.;Gargano, Julia Warner;Powell, Melissa;Park, Ina U.;Niccolai, Linda M.;Bennett, Nancy M.;Griffin, Marie R.;Querec, Troy;Unger, Elizabeth R.;Markowitz, Lauri E.; Corporate Authors(s) : HPV-IMPACT Working Group Published Date : 4 02 2020;4-02-; Source : Am J Epidemiol. 189(4):265-276 URL : https://stacks.cdc.gov/view/cdc/115080 Johnson Jones, Michelle L. et al. (2020). Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18. 189(4). Johnson Jones, Michelle L. et al. "Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18" 189, no. 4 (2020) Johnson Jones, Michelle L. et al. "Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18" vol. 189, no. 4, 2020 Export RIS Citation Information.

:

Johnson Jones, Michelle L. ;

Gargano, Julia Warner

4 02 2020 | Am J Epidemiol. 189(4):265-276

:

Before 2016, human papillomavirus (HPV) vaccination was recommended on a 3-dose schedule. However, many vaccine-eligible US females received fewer tha...

To see more results, try removing search filters or changing the search terms